A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis
Osteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/10/2467 |
id |
doaj-095644ec85b84b95a502ca50e656a920 |
---|---|
record_format |
Article |
spelling |
doaj-095644ec85b84b95a502ca50e656a9202020-11-25T00:39:42ZengMDPI AGNutrients2072-66432019-10-011110246710.3390/nu11102467nu11102467A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of OsteoporosisAngela Fabiano0Anna Maria Piras1Vincenzo Calderone2Lara Testai3Lorenzo Flori4Dario Puppi5Federica Chiellini6Ylenia Zambito7Department of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyDepartment of Chemistry and Industrial Chemistry, University of Pisa, Udr INSTM Pisa, Via Moruzzi 13, 56124 Pisa, ItalyDepartment of Chemistry and Industrial Chemistry, University of Pisa, Udr INSTM Pisa, Via Moruzzi 13, 56124 Pisa, ItalyDepartment of Pharmacy, University of Pisa, via Bonanno 33, 56126 Pisa, ItalyOsteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a formulation able to gradually release calcium during transit over the GI tract, thus increasing bioavailability and reducing daily dose, and hence, side effects. Calcium controlled-release granules based on zeolite and Precirol<sup>®</sup> were prepared. In the best case, represented by granules sized 1.2 mm, containing 20% Precirol<sup>®</sup>, 19% zeolite, 60% calcium (granule), the release lasted ≈6 h. The release is controlled by diffusion of calcium ions through the aqueous channels forming within granules, once these come into contact with physiological fluids. Such a diffusion is hindered by the interaction of calcium ions with the negatively charged surface of the zeolite. Ovariectomy was used to make rats osteopenic. For in vivo studies, rats were divided into the following groups. Sham: not treated; ova: ovariectomized (ova); CaCl<sub>2</sub> 1.0 g: ova, treated with 1.0 g/die Ca<sup>2+</sup>; CaCl<sub>2</sub> 0.5 g: ova, treated with 0.5 g/die Ca<sup>2+</sup>; granule 1.0 g, or granule 0.5 g: ova, treated with granules equivalent to 1.0 g/die or 0.5 g/die Ca<sup>2+</sup> in humans. Ca<sup>2+</sup> amounts in femur bone and bone marrow, femur mechanical characteristics, and femur medullary canalicule diameter were measured and the same efficacy rank order was obtained: ova < CaCl<sub>2</sub> 0.5 g < CaCl<sub>2</sub> 1.0 g < granule 0.5 g ≈ granule 1.0 g ≈ sham. The results show promise of an effective prevention of osteoporosis, based on a controlled-rate administration of a calcium dose half that administered by the current therapy, with reduced side effects.https://www.mdpi.com/2072-6643/11/10/2467calcium zeoliteprecirol<sup>®</sup> granulescalcium controlled releaseosteopenic ratsfemur mechanical characterizationfemur morphological characterization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Angela Fabiano Anna Maria Piras Vincenzo Calderone Lara Testai Lorenzo Flori Dario Puppi Federica Chiellini Ylenia Zambito |
spellingShingle |
Angela Fabiano Anna Maria Piras Vincenzo Calderone Lara Testai Lorenzo Flori Dario Puppi Federica Chiellini Ylenia Zambito A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis Nutrients calcium zeolite precirol<sup>®</sup> granules calcium controlled release osteopenic rats femur mechanical characterization femur morphological characterization |
author_facet |
Angela Fabiano Anna Maria Piras Vincenzo Calderone Lara Testai Lorenzo Flori Dario Puppi Federica Chiellini Ylenia Zambito |
author_sort |
Angela Fabiano |
title |
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis |
title_short |
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis |
title_full |
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis |
title_fullStr |
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis |
title_full_unstemmed |
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis |
title_sort |
new calcium oral controlled-release system based on zeolite for prevention of osteoporosis |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2019-10-01 |
description |
Osteoporosis, a systemic skeleton disease, can be prevented by increasing calcium levels in serum via administration of calcium salts. However, traditional calcium-based formulations have not appeared to be effective, hence the purpose of the present work has been to prepare and test in vitro/vivo a formulation able to gradually release calcium during transit over the GI tract, thus increasing bioavailability and reducing daily dose, and hence, side effects. Calcium controlled-release granules based on zeolite and Precirol<sup>®</sup> were prepared. In the best case, represented by granules sized 1.2 mm, containing 20% Precirol<sup>®</sup>, 19% zeolite, 60% calcium (granule), the release lasted ≈6 h. The release is controlled by diffusion of calcium ions through the aqueous channels forming within granules, once these come into contact with physiological fluids. Such a diffusion is hindered by the interaction of calcium ions with the negatively charged surface of the zeolite. Ovariectomy was used to make rats osteopenic. For in vivo studies, rats were divided into the following groups. Sham: not treated; ova: ovariectomized (ova); CaCl<sub>2</sub> 1.0 g: ova, treated with 1.0 g/die Ca<sup>2+</sup>; CaCl<sub>2</sub> 0.5 g: ova, treated with 0.5 g/die Ca<sup>2+</sup>; granule 1.0 g, or granule 0.5 g: ova, treated with granules equivalent to 1.0 g/die or 0.5 g/die Ca<sup>2+</sup> in humans. Ca<sup>2+</sup> amounts in femur bone and bone marrow, femur mechanical characteristics, and femur medullary canalicule diameter were measured and the same efficacy rank order was obtained: ova < CaCl<sub>2</sub> 0.5 g < CaCl<sub>2</sub> 1.0 g < granule 0.5 g ≈ granule 1.0 g ≈ sham. The results show promise of an effective prevention of osteoporosis, based on a controlled-rate administration of a calcium dose half that administered by the current therapy, with reduced side effects. |
topic |
calcium zeolite precirol<sup>®</sup> granules calcium controlled release osteopenic rats femur mechanical characterization femur morphological characterization |
url |
https://www.mdpi.com/2072-6643/11/10/2467 |
work_keys_str_mv |
AT angelafabiano anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT annamariapiras anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT vincenzocalderone anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT laratestai anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT lorenzoflori anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT dariopuppi anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT federicachiellini anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT yleniazambito anewcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT angelafabiano newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT annamariapiras newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT vincenzocalderone newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT laratestai newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT lorenzoflori newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT dariopuppi newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT federicachiellini newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis AT yleniazambito newcalciumoralcontrolledreleasesystembasedonzeoliteforpreventionofosteoporosis |
_version_ |
1725293049608667136 |